Hyderabad Pharma Firm Signs Agreement To Make Covid Drug 2-DG

Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-DG used to treat...

from NDTV News - Special https://ift.tt/3g7iA7F